Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institutul De Cercetari Chimico-FarmaceuticefiledCriticalInstitutul De Cercetari Chimico-Farmaceutice
Priority to RO111722ApriorityCriticalpatent/RO86638B1/ro
Publication of RO86638A2publicationCriticalpatent/RO86638A2/ro
Publication of RO86638B1publicationCriticalpatent/RO86638B1/ro
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
Compozitia medicamentoasa radioopaca, conform inventiei, este constituita din 85...95% sulfat de bariu, 0,5...2p alginat de sodiu 5...15 p sorbitol, 0,2...0,9 p tween 80, 0,1...0,3 p ulei de menta, doza de administrare pentru o data fiind de 135 p pulbere care se disperseaza în 300 ml apa si serveste la explorarea radiologica a mucoasei tubului digestiv.
Pharmaceutically acceptable salts of 4'-(9-acridinylamino) methanesulfon-m-anisidide, their production, and pharmaceutical compositions containing such salts